I'm certainly extremely confident to back our Aussie scientists and the Rhythm business team over all the rest. 13 years of research by the CSIRO, then 4 years with Rhythm to ultimately identify 1 lead protein bio marker and 4 adjunct markers (all non-DNA = low cost test) resulting in 91% specificity and 81% sensitivity across some 850 clinical trial patients in the 7th study conducted by huge medical company Sonic! Management from CSL, Johnson & Johnson, Avita, Monash IVF, CSIRO, Pfizer. All this in one of the most highly regulated societies in the world.
Show me the company that has the same track record worthy of our trust!
RHY Price at posting:
98.5¢ Sentiment: Buy Disclosure: Held
